Downregulation of the expression of bone morphogenetic protein 7 in experimental pyelonephritis

Pediatric Nephrology

Volumn 20, Issue 9, 2005, Pages 1230-1236

  Biyikli, Nese Karaaslan ^a,b   Tugtepe, Halil ^a   Cakalagaoglu, Fulya ^a   Ilki, Arzu ^a   Alpay, Harika ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Acute pyelonephritis; Bone morphogenetic protein (BMP 7); Chronic pyelonephritis; Experimental; Fibrosis

Indexed keywords

CREATININE; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PYELONEPHRITIS; CONTROLLED STUDY; HISTOPATHOLOGY; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEINURIA; RAT; RAT STRAIN;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FIBROSIS; MALE; PROTEINS; PYELONEPHRITIS; RATS;

EID: 24044443901     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-1927-4     Document Type: Article

References (29)

1. Rushton HG, Majd M, Jantausch B, Wiedermann BL, Belman AB (1992) Renal scarring following reflux and nonreflux pyelonephritis in children: evaluation with 99mTechnetium dimercaptosuccinic acid (DMSA) scintigraphy. J Urol 147:1327 1314912
2. Sirin A, Emre S, Alpay H, Nayir A, Bilge I, Tanman F (1995) Etiology of chronic renal failure in Turkish children. Pediatr Nephrol 9(5):549-552 10.1007/BF00860926
3. Heptinstall RH (1992) Pyelonephritis: Pathologic features. In Heptinstall RD (eds) Pathology of the kidney, 4th edn. Little Brown, Boston, pp 1489-1561
4. Wolfman NM, Hattesley G, Cox K (1997) Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7 numbers of the TGF-beta gene family. J Clin Invest 100:321-330 9218508
5. Kim RY, Robertson EJ, Solloway MJ (2001) Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev Biol 235:449-466 10.1006/dbio.2001.0284
6. Jena N, Martin-Seisdedos C, McCue P, Croce CM (1997) BMP7 null mutation in mice: Developmental defects in skeleton, kidney, and eye. Exp Cell Res 230:28-37 10.1006/excr.1996.3411
7. Luo G, Hofmann C, Bronckers AL, Sohocki M, Bradley A, Karsenty G (1995) BMP 7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820 7590255
8. Dudley AT, Lyons KM, Robertson EJ (1995) A requirement for bone morphogenetic protein-7 during development of mammalian kidney and eye. Genes Dev 9:2795-2807 7590254
9. Simon M, Maresh JG, Harris SE, Hernandez JD, Arar M, Olson MS, Abboud HE (1999) Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol 276: F382-F389 10070161
10. Gould SE, Day M, Jones SS, Dorai H (2002) BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int 61:51-60 10.1046/j.1523-1755.2002.00103.x
11. Vukicevic S, Basic V, Rogic D, Basic N, Shih MS, Shepard A, Jin D, Dattatreyamurty B, Jones W, Dorai H, Ryan S, Griffiths D, Maliakal J, Jelic M, Pastorcic M, Stavljenic A, Sampath TK (1998) Osteogenic protein-1 (bone morphogenetic protein-7) reduces severity of injury after ischemic acute renal failure in rat. J Clin Invest 102:202-214 9649574
12. Hruska K, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, Morrissey J (2000) Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am J Physiol 279: F130-F143
13. Wang S, Chen O, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, Hruska KA (2003) Bone morphogenic protein 7 (BMP- 7), a novel therapy for diabetic nephropathy. Kidney Int 63 (6):2037-2349 10.1046/j.1523-1755.2003.00035.x
14. Almanzar MM, Frazier KS, Dube PH, Piqueras AI, Jones WK, Charette MF, Paredes AL (1998) Osteogenic protein-1 mRNA expression is selectively modulated after acute ischemic renal injury. J Am Soc Nephrol 9 (8):1456-1463 9697668
15. Haraoka M, Matsumoto T, Takahashi K, Kubo S, Tanaka M, Kumazawa J (1994) Supression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J Urol 151:1078-1080 8126797
16. Kavukcu S, Soylu A, Turkmen M, Sarioglu S, Buyukgebiz B, Gure A (1999) The role of vitamin A in preventing renal scarring secondary to pyelonephritis. BJU Int 83:1055-1059 10.1046/j.1464-410x.1999.00063.x
17. Tokunaga S, Ohkawa M, Nakamura S (1993) An experimental model of ascending pyelonephritis due to Candida albicans in rats. Mycopathologia 123:149-154 10.1007/BF01111265
18. Androulakakis PA, Ransley PG, Risdon RA, Sorger K, Hohenfellner R (1987) Microvascular changes in the early stage of reflux pyelonephritis. An experimental study in the pig kidney. Eur Urol 13 (4):219-223 3308470
19. Morrissey J, Hruska K, Guo G, Wang S, Chen O, Klahr S (2002) Bone morphogenetic protein-7 (BMP-7) improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13 (suppl):S14-S21 10.1097/01.ASN.0000017905.77985.4A
20. Kalluri R, Zeisberg M (2003) Exploring the connection between chronic renal fibrosis and bone morphogenetic protein-7. Histol Histopathol 18(1):217-224 12507301
21. Reddi AH (2000) Bone morphogenetic proteins and skeletal development: the kidney bone connection. Pediatr Nephrol 14:598-601 10.1007/ s004670000364
22. Brock 3rd J, Hunley T, Adams M, Kon V (1998) Role of the renin-angiotensin system in disorders of the urinary tract. J Urol 160:1812-1819 10.1097/00005392-199811000-00063
23. Border WA, Noble NA (1998) Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 31:181-188 9453300
24. Ma LJ, Yang H, Gaspert A, Carlesso G, Barty MM, Davidson JM, Sheppard D, Fogo AB (2003) Transforming growth factor-beta-dependent and independent pathways of induction of tubulointerstitial fibrosis in beta 6 (-/-) mice. Am J Pathol 163 (4):1261-1273 14507636
25. Yamashita S, Maeshima A, Kojima I, Nojima Y (2004) Activin A is a potent activator of renal interstitial fibrosis. J Am Soc Nephrol 15(1):91-101 10.1097/01.ASN.0000103225.68136.E6
26. Negri Al (2004) Prevention of progressive fibrosis in chronic renal diseases: Antifibrotic agents. J Nephrol 17(4):496-503 15372410
27. Khalil A, Tullus K, Bakhiet M, Burman LG, Jaremko G, Brauner A (2000) Angiotensin II type I receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis. J Urol 164 (1):186-191 10.1097/00005392-200007000-00058
28. Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charyton D, Strutz F, Kalluri R (2003) BMP 7 counteracts TGF-b1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9:964-968 10.1038/nm888
29. Wang SN, Lapage J, Hirschberg R (2001) Loss of bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 12:2392-2399 11675415